What FDA Warnings Exist for GLP-1 Medications?
Last updated: January 2026
Quick Answer
GLP-1 medications carry a black box warning for thyroid C-cell tumors (based on rodent studies) and warnings about pancreatitis, gallbladder disease, and kidney problems.
What FDA Warnings Exist for GLP-1 Medications
GLP-1 medications carry a black box warning for thyroid C-cell tumors (based on rodent studies) and warnings about pancreatitis, gallbladder disease, and kidney problems.
Safety is the most important consideration when starting any medication. GLP-1 medications have been extensively studied in clinical trials involving tens of thousands of patients, and they have a well-established safety profile when prescribed and monitored by licensed healthcare providers.
What the Research Shows
The STEP and SURMOUNT clinical trial programs included over 25,000 participants combined. These large-scale studies established the efficacy and safety profile that led to FDA approval for weight management.
Staying Safe on GLP-1 Treatment
- Only obtain GLP-1 medications through licensed healthcare providers and pharmacies
- Follow your prescribed dosing schedule and titration plan
- Report any unusual symptoms to your provider promptly
- Attend regular follow-up appointments for monitoring
- Inform all your healthcare providers that you take GLP-1 medications
- Keep medications stored properly and check expiration dates
Related Questions
Do GLP-1 Medications Cause Thyroid Cancer?
Thyroid tumors were found in rodent studies at high doses. Clinical significance in humans is unknown. GLP-1 is contraindicated if you have MTC history.
Do GLP-1 Medications Cause Pancreatitis?
Pancreatitis is rare (less than 1%) but serious. Tell your provider about any history of pancreatitis. Seek emergency care for severe abdominal pain.